| |
|
|
|
Xtalks, online
2023 -6-28
The current barriers to success of clinical trials include issues like difficulties in recruitment, low adherence to clinical trial protocols, high drop-out rates, and costly resubmission of protocols, all of which have a negative impact on a sponsor’s timeline and budget.
Engaging with patients – and their caregivers and advocates – during the planning and execution of clinical trials is crucial. When patients are involved in the clinical development plan and creation of the trial protocol and are encouraged to provide in-trial feedback, they are more likely to stay in the trial, understand their responsibilities, and adhere to the protocol requirements. Working in partnership with patients can ensure impactful clinical benefit of treatments that address important unmet patient needs prioritized from the patient’s perspective.
In recent years, pharma and MedTech companies have become much more conscious of the role of patients in product development, including the potential of including their input in the clinical research stage. Patient, caregiver, and advocate insights can help sponsors and researchers plan and execute accessible clinical trials with more feasible protocols, improved inclusion/exclusion criteria, and meaningful endpoints, ideally yielding completed trials with more impactful results while also saving time and financial resources.
However, lack of awareness, resources, and time to participate in patient engagement activities can negatively affect a company’s ability to benefit from patient input.
How do sponsors and researchers engage patients in the development lifecycle and make the most of their involvement in clinical trials?
In this webinar, our experts will review the range of tools that enable patient engagement during the clinical research stage of drug development.
During this webinar you will learn:
How to properly inform patients who are considering participation in a clinical trial
How to properly include patient feedback in creating primary and secondary endpoints in a trial
How to investigate that clinical protocols address all patients’ symptoms in addition of addressing the primary need
How to co-create a protocol with patients and/or review it with them and incorporate their feedback
How to keep patients engaged after the trial ends for future data collection
The goal of every patient and their families is to have access to successful treatments that fully address their medical needs, with minimal invasion of their lives (time, pain, anxiety etc.). Therefore, patients should be working side by side with industry and regulators to make sure that new products indeed satisfy the above characteristics.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Giulia Pierini, Associate Director, Patient Engagement, Alira Health (Moderator) Annabel de Maria, Chief Patient Officer, Alira Health Dr. Giacomo Basadonna, MD, Chief Medical Officer, Head of Global Medical Strategy, Alira Health
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -6-28
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|